Your session is about to expire
← Back to Search
CC+ECIG Condition for Substance Abuse
Study Summary
This trial will evaluate the effectiveness of a retraining program to help people quit smoking cigarettes and using electronic cigarettes. The study will follow 90 experienced users who are motivated to quit as they try to quit on their own.
- Substance Abuse
- Tobacco Smoking
- Vaping
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the participant demographic for this trial limited to those over 20 years of age?
"This study is open to individuals aged 18 and up, but no older than 85."
Is there still an opportunity to join in this research endeavor?
"Affirmative. According to clinicaltrials.gov, this research has been recruiting participants since October 1st 2022 and is still actively doing so at present. 90 patients are needed from a single healthcare facility for the trial to meet its goals."
What is the maximum number of participants approved to join this research endeavor?
"Affirmative. Information on clinicaltrials.gov affirms that recruitment for this medical trial, which launched in October 1st 2022, is ongoing. It plans to recruit 90 people from a single site."
Are there any prerequisites for participation in this clinical trial?
"This clinical trial is recruiting 90 participants aged 18-85 who are habitual nicotine users. The essential prerequisites for enrolment include: the minimum age of consent, ability to speak and read English fluently, owning an android phone (for EMA purposes), a strong desire to quit using nicotine products, and no reduction in CC or ECIG usage by more than half within the last month."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger